DE69229597D1 - Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert - Google Patents

Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert

Info

Publication number
DE69229597D1
DE69229597D1 DE69229597A DE69229597A DE69229597D1 DE 69229597 D1 DE69229597 D1 DE 69229597D1 DE 69229597 A DE69229597 A DE 69229597A DE 69229597 A DE69229597 A DE 69229597A DE 69229597 D1 DE69229597 D1 DE 69229597D1
Authority
DE
Germany
Prior art keywords
erbb
growth factor
receptor
induces
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69229597A
Other languages
English (en)
Other versions
DE69229597T2 (de
DE69229597T4 (de
Inventor
Marc Lippman
Ruth Lupu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Application granted granted Critical
Publication of DE69229597D1 publication Critical patent/DE69229597D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/4756Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16HIV-1 ; HIV-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69229597A 1991-01-14 1992-01-13 Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert Expired - Fee Related DE69229597D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64049791A 1991-01-14 1991-01-14
PCT/US1992/000329 WO1992012174A1 (en) 1991-01-14 1992-01-13 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES

Publications (1)

Publication Number Publication Date
DE69229597D1 true DE69229597D1 (de) 1999-08-19

Family

ID=24568503

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69229597A Expired - Fee Related DE69229597D1 (de) 1991-01-14 1992-01-13 Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert
DE69229597T Expired - Lifetime DE69229597T4 (de) 1991-01-14 1992-01-13 Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69229597T Expired - Lifetime DE69229597T4 (de) 1991-01-14 1992-01-13 Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert

Country Status (9)

Country Link
EP (1) EP0574414B1 (de)
JP (1) JPH06505011A (de)
KR (1) KR930703359A (de)
AT (1) ATE182152T1 (de)
AU (2) AU1227792A (de)
CA (1) CA2100549A1 (de)
DE (2) DE69229597D1 (de)
NZ (1) NZ241292A (de)
WO (1) WO1992012174A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7115554B1 (en) 1993-05-06 2006-10-03 Acorda Therapeutics, Inc. Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
US7319019B1 (en) 1991-04-10 2008-01-15 Acorda Therapeutics, Inc. Glial mitogenic factors lacking an N-terminal signal sequence
US7285531B1 (en) 1991-04-10 2007-10-23 Acorda Therapeutics, Inc. Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
US7094749B1 (en) 1991-04-10 2006-08-22 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US7135456B1 (en) 1991-04-10 2006-11-14 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5367060A (en) * 1991-05-24 1994-11-22 Genentech, Inc. Structure, production and use of heregulin
WO1994003644A1 (en) * 1992-08-10 1994-02-17 Cambridge Neuroscience, Inc. Inhibitors of cell proliferation, their preparation and use
GB9217316D0 (en) * 1992-08-14 1992-09-30 Ludwig Inst Cancer Res Schwann cell mitogenic factor,its preparation and use
US5770567A (en) * 1994-11-14 1998-06-23 Genentech, Inc. Sensory and motor neuron derived factor (SMDF)
US5912326A (en) * 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030565A (en) * 1983-08-17 1991-07-09 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal receptors to protein ligands
ATE153858T1 (de) * 1990-04-06 1997-06-15 Univ Pennsylvania Ligand für das neu-gen-produkt

Also Published As

Publication number Publication date
NZ241292A (en) 1994-04-27
EP0574414B1 (de) 1999-07-14
ATE182152T1 (de) 1999-07-15
DE69229597T2 (de) 2000-05-04
AU5601896A (en) 1996-08-29
JPH06505011A (ja) 1994-06-09
DE69229597T4 (de) 2000-08-17
KR930703359A (ko) 1993-11-29
EP0574414A4 (de) 1994-12-21
AU1227792A (en) 1992-08-17
CA2100549A1 (en) 1992-07-15
WO1992012174A1 (en) 1992-07-23
EP0574414A1 (de) 1993-12-22

Similar Documents

Publication Publication Date Title
DE69229597D1 (de) Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert
EP1028315A3 (de) Zielspezifische Screens und ihre Verwendung zur Ermittelung von kleinen organischen molekularen Pharmakophoren
DE69714654D1 (de) Verwendung von einem Metalloporphyrinkonjugat für den Nachweis biologischer Verbindungen
ATE377081T1 (de) Material und verfahren die hybridvaskularendothelwachstumfaktoren dns und proteine enthalten und screeningverfahren für modulatoren
Lal et al. Clean Western blot signals from immunoprecipitated samples
ES2090211T3 (es) Ensayos de fijacion a receptores, exentos de celulas, su produccion y utilizacion.
ATE146222T1 (de) Interzellulares adhäsions-molekül-2 und seine bindungsliganden
GR3034267T3 (en) Domains of extracellular region of human platelet derived growth factor receptor polypeptides.
HUS1400027I1 (hu) OBM elleni antitestek
IT8448736A1 (it) Recettori monoclonali indotti da polipeptidi per leganti proteinici
BR0209933A (pt) Uso de um ativador da transmembrana e modulador de cálcio, e proteìna de fusão de (taci) - imunoglobulina interatuadora do ligando da ciclofilina, proteìna de fusão, molécula de ácido nucleico, e, composição farmacêutica
DK439885D0 (da) Baeremateriale til anvendelse ved immunbestemmelser
DE69022337D1 (de) 2-Stufenverfahren zur Synthese von Kohlenwasserstoffen.
ATE332914T1 (de) Mimotope und antimimotope des menschlichen plättchen-glykoproteins ib/ix
ATE200579T1 (de) Screening-verfahren zur ligand-identifizierung von zielproteinen
ATE125708T1 (de) Interzellulare adhäsions-moleküle und deren bindungsliganden.
BR9004848A (pt) Novo meio contendo ligante,para adsorcao cromatografica,coluna cromatografica de afinidade e processo para preparar um meio de afinidade de avidina aperfeicoado
WO2003054514A3 (en) Novel parallel throughput system
Park et al. Analysis of calcium binding proteins of mouse epididymal spermatozoa

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee